CompuMed (OTCMKTS:CMPD) Trading Up 1.5% – Should You Buy?

Shares of CompuMed Inc. (OTCMKTS:CMPDGet Free Report) were up 1.5% on Wednesday . The stock traded as high as $6.00 and last traded at $6.00. Approximately 310 shares changed hands during trading, a decline of 82% from the average daily volume of 1,719 shares. The stock had previously closed at $5.91.

CompuMed Price Performance

The stock has a market capitalization of $7.98 million, a price-to-earnings ratio of -40.00 and a beta of -0.48. The company has a quick ratio of 2.34, a current ratio of 2.37 and a debt-to-equity ratio of 0.12. The stock has a fifty day moving average of $6.26 and a 200-day moving average of $6.01.

CompuMed (OTCMKTS:CMPDGet Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.06) earnings per share for the quarter. CompuMed had a negative return on equity of 6.47% and a negative net margin of 2.51%.The company had revenue of $2.03 million for the quarter.

About CompuMed

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

See Also

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.